Consumer Cyclical
Ethos Limited (NSE: ETHOSLTD) breaks out, gains 6% intraday
Ethos Limited (NSE: ETHOSLTD) stock price gains 6% intraday, breaking out above its 6-month resistance trendline at ₹2696.
Ethos Limited (ETHOSLTD) breaks out with a +6% gain to ₹2742.1 on the NSE today, clearing its 6-month resistance trendline. This move comes after the company’s recent investor presentation and the announcement of the resignation of an independent director, though the primary catalyst appears to be the technical breakout. Ethos Limited operates in the luxury goods segment of the consumer cyclical sector, and today’s move seems to be more company-specific rather than a sector-wide trend.
Technical setup — trendlines & DMA
From a technical standpoint, Ethos Limited has broken out above its 6-month resistance trendline, which ended at ₹2696.43, marking a 1.67% clear. The 6-month support trendline stands at ₹2518.03, which is 8.17% below the current price, providing a solid floor. The 50-day moving average (DMA) at ₹2469.0 is currently below the 200-DMA at ₹2585.3, indicating a bearish trend. However, the stock’s current price is above the 50-DMA but still below the 200-DMA, suggesting a mixed position. In terms of its 52-week range, the stock is trading in the middle third, 62% up from the 52-week low and 15.5% below the 52-week high, implying there is room for further upside if momentum continues.
Snapshot: ₹2,742.10 on 2026-08-03 (chart frozen at publication)
Fundamentals & business context
On the fundamental front, Ethos Limited’s PE of 71.0, coupled with a profit margin of 5.9%, raises questions about the valuation relative to the company’s earnings. The revenue CAGR of 26.9% indicates strong growth, but the profit CAGR of 16.3% suggests that growth is not fully translating into bottom-line improvements. The 31.0% institutional ownership suggests that while there is some interest from smart money, the valuation may be stretched given the current earnings and growth rates. There is no specific NSE catalyst today beyond the technical breakout and recent corporate announcements.
Algorithmic scorecard
The algorithmic scorecard reflects a company with strong growth metrics but facing valuation and technical challenges. The revenue CAGR of 26.9% and the consistent revenue growth every year highlight the company’s excellent business stability and growth potential. However, the low profit margin of 5.9% and the overvalued PEG of 4.36 indicate that the stock may be priced aggressively relative to its growth. On the technical side, the bearish trend signaled by the 50-DMA below the 200-DMA and the stock’s decline of 7.2% in the last year suggest caution. The strong momentum across all timeframes and low volatility, with a beta of 0.10, offer some reassurance but do not offset the fundamental and technical concerns.
Get all details on ETHOSLTD — P&L, peers, shareholding and more on TradeAlone.
Consumer Cyclical
Mold-tek Packaging Limited Q2 FY27: Net Profit Up 36.06%, Sales Volume Grows 10.08%
Mold-Tek Packaging Limited reports a 36.06% increase in net profit and a 10.08% rise in sales volume for Q2 FY27.
Mold-Tek Packaging Limited (NSE: MOLDTKPAC) announced its financial results for the quarter and half-year ended September 30, 2026. Despite the uncertain geopolitical situation, the company achieved a 36.06% increase in net profit and a 10.08% rise in sales volume during Q2 FY2027, reflecting resilient business performance and sustained demand across its key packaging segments.
Key Financial Highlights
The company delivered strong financial performance during Q2 FY2027, registering healthy growth across all key financial parameters. The key highlights are:
Net Profit: Net profit increased by 36.06% to ₹21.09 crore.
Revenue: Revenue increased by 30.73% to ₹274.23 crore.
EBITDA: EBITDA grew by 29.80% to ₹51.27 crore.
Sales Volume: Sales volume increased by 10.08% to 11,028.46 MT.
Segment-wise Performance
Mold-Tek Packaging Limited’s segment-wise performance for Q2 FY2027 compared to Q2 FY2026:
Pharma Packaging: Delivered an excellent volume growth of 26.30%, emerging as one of the key growth drivers.
Food & FMCG Packaging: Registered robust volume growth of 23.70%, reflecting strong demand in the segment.
Paints Packaging: Recorded a steady volume growth of 8.61%.
Lubricants Packaging: Witnessed a volume decline of 12.32%.
The strong growth in Food & FMCG and Pharma Packaging, supported by steady performance in Paints Packaging, more than offset the moderation in Lubricants Packaging, enabling the company to achieve an overall sales volume growth of 10.08% year-on-year during Q2 FY2027.
Future Prospects
Mold-Tek Packaging Limited is starting commercial production of IODEX containers from Q3 FY27 and other new packs are under development for 3 more new multinational companies. These products are expected to add revenues from Q4 FY27. Eye dropper pack moulds are expected to be ready by Q4 and commercial production from Q1 FY28. The company is also actively working on entering into Trays, Dosing Pens and Semi-conductors packaging for sustaining growth for the next few years.
Source: NSE Corporate Announcement
Fundamental & Technical Analysis of Mold-Tek Packaging Limited
Mold-Tek Packaging Limited belongs to the Consumer Cyclical › Packaging & Containers sector. Here’s a quick read on where the business and the stock stand today.
Mold-Tek falls 54.6% over three months and has not found a floor yet. Thin margins at 8.0% leave limited room for error — any demand softness or cost spike hits the bottom line hard. Revenue contracts at 6.7% CAGR. That signals structural headwinds, not a short-term blip. RSI stands at 15, well into oversold territory. Yet sellers still dominated on 19 of recent sessions versus 11 for buyers, so the pressure has not fully lifted. Revenue grows at 6.7% CAGR and the PEG stands at 99.00. The growth does not match the price the market asks. Furthermore, flat price action adds no technical catalyst. A lower price or faster revenue growth would improve the odds. Check Fundamentals of Mold-Tek Packaging Limited.
Consumer Cyclical
Taj GVK Hotels & Resorts Limited (tajgvk) Announces Growth Plans and Upcoming Opening of Taj Yelahanka
Taj GVK Hotels & Resorts Limited (TAJGVK) reveals growth plans and upcoming opening of Taj Yelahanka, emphasizing market and economic conditions.
Taj GVK Hotels & Resorts Limited (TAJGVK) has unveiled its growth plans and announced the upcoming opening of Taj Yelahanka. The company’s Chief Financial Officer, Mr. Srinivas Murthy, highlighted the strategic importance of this new venture. The opening is expected to significantly boost the company’s presence in the luxury hotel sector. However, the company emphasized that these plans are contingent upon market and economic conditions, competition, regulatory approvals, and execution.
Strategic Growth Plans
The announcement underscores Taj GVK Hotels & Resorts Limited’s commitment to expanding its portfolio. The company aims to leverage its expertise in luxury hospitality to enhance its market footprint. Notably, the opening of Taj Yelahanka is part of a broader strategy to capture new market segments and drive revenue growth.
Market and Economic Considerations
As the company moves forward with its plans, it acknowledges the inherent risks and uncertainties. Mr. Murthy pointed out that while the growth plans are ambitious, they are based on management’s current expectations. As a result, the company remains cautious about potential market fluctuations and regulatory challenges.
In conclusion, Taj GVK Hotels & Resorts Limited (TAJGVK) is poised to make significant strides in the hospitality industry. The upcoming opening of Taj Yelahanka is a testament to the company’s vision and determination to succeed in a competitive landscape.
Source: NSE Corporate Announcement
Fundamental & Technical Analysis of Taj GVK Hotels & Resorts Limited
Taj GVK Hotels & Resorts Limited belongs to the Consumer Cyclical › Lodging sector. Here’s a quick read on where the business and the stock stand today.
Taj falls 10.2% over three months and has not found a floor yet. The PEG of 0.07 is extremely low. Either the market misses the growth story, or there is a catch worth investigating. Industry-leading margins of 73.1% reflect exceptional pricing power and operational efficiency. The stock holds at 27% of its 52-week range with RSI at 48. In other words, neither side has a clear edge right now. Revenue grows at 9.8% and profits at 72.3% CAGR — a genuinely strong business. Nevertheless, the stock drops 10.2% in three months. The market sells the stock, not the story. Watch whether that changes at the next earnings. Check Fundamentals of Taj GVK Hotels & Resorts Limited.
Consumer Cyclical
Devyani International Limited (devyani) Q2 Fy2027 Results: Strong Revenue Growth and Margin Improvement
Devyani International Limited (DEVYANI) announces Q2 FY2027 results with 10.4% YoY revenue growth, strong SSSGs, and improved margins.
Devyani International Limited (DEVYANI), one of India’s leading global Quick Service Restaurant (QSR) operators, has announced its financial results for the quarter ended September 30, 2026. The company reported a robust performance with a 10.4% year-over-year (YoY) increase in revenues, reaching Rs. 1,5194 million. The company’s same-store sales growth (SSSG) accelerated across most of its portfolio, including KFC, Costa, and BBK.
Store Expansion and Margin Improvement
The company added 70 new stores during the quarter, with KFC leading the additions with 50 new units in India. This expansion brings the total store network to 2,325 globally and 1,923 in India. The operating EBITDA grew by 34% YoY to INR 1,251 Mn, with a margin of 8.2%. The company also delivered a Profit before Tax (PBT) of INR 57 Mn for the quarter, turning around from a loss last year.
Positive Financial Performance
Commenting on the performance, Mr. Ravi Jaipuria, Chairman of Devyani International Limited, said, “Our growth momentum carried on firmly into the second quarter. We have had a good quarter with positive SSSGs ranging from 4% to 9% across our brand portfolio in India except PH which saw sequentially better numbers. Despite steep inflation in raw materials and wages, the leverage from higher same-store sales and tight cost control helped us lift the EBITDA by nearly 18%, to INR 229 Cr.”
The company is on track to meet its full-year guidance of 200-220 net new additions, with the same discipline: the right locations and a clear line of sight to profitability. Equally encouraging is the quality of growth that we are observing. Across brands, we have witnessed transaction-led growth – and growth in our on-premises channel sales. Both these trends are very heartening and are key to a long-term sustainable growth trajectory.
Source: NSE Corporate Announcement
Fundamental & Technical Analysis of Devyani International Limited
Devyani International Limited belongs to the Consumer Cyclical › Restaurants sector. Here’s a quick read on where the business and the stock stand today.
Devyani posts a 8.9% three-month gain, but softens in the last few weeks. D/E reaches 2.27. High leverage in this environment is a material risk the market cannot ignore. Razor-thin margins below 5% make profitability extremely vulnerable — this business needs scale or pricing power urgently. The stock gives back 10.8% in the last month despite a positive three-month run. As a result, the earlier momentum appears to be fading. Revenue grows at 23.3% CAGR and the PEG stands at 99.00. The growth does not match the price the market asks. Furthermore, flat price action adds no technical catalyst. A lower price or faster revenue growth would improve the odds. Check Fundamentals of Devyani International Limited.
-
Basic Materials3 days agoVenus Pipes & Tubes Limited (venuspipes) Secures Rs. 29 Crore Order for Pipe Spooling Solutions
-
Advertising Agencies3 days agoAffle 3i Limited (affle) Reports Robust Q2 & H1 Fy2027 Performance: Revenue and Ebitda Growth
-
Consumer Defensive3 days agoCrizac Limited Q2 FY27: Total Income Down 34.5%, Declares ₹4 Interim Dividend
-
AARTIIND3 days agoAarti Industries Limited (aartiind) Q2 FY27: Revenue and Ebitda Surpass Expectations
-
APLLTD3 days agoAlembic Pharmaceuticals Limited (aplltd) Receives USFDA Final Approval for Venetoclax Tablets
-
DELHIVERY3 days agoDelhivery Limited (NSE: Delhivery) Q2fy27: ₹3,000 Cr Revenue Milestone, Ebitda Triples Yoy
-
Industrials3 days agoRamkrishna Forgings Limited (rkforge) Q2 FY27: Forging Ahead with 55% Yoy Revenue Surge
-
ASIANENE3 days agoAsian Energy Services Limited (asianene) Q2fy27: Revenue Up 161%, Profitability Soars